Breakthrough Research on Lung Cancer Cell Metabolism and Immunotherapy Response
New Insights into Lung Cancer Treatment
New Delhi, Feb 4: Researchers in Australia have successfully mapped the "neighborhoods" of lung cancer cells, revealing that cellular metabolism significantly influences patient responses to immunotherapy.
Scientists from the University of Queensland's Frazer Institute conducted a detailed study on cell interactions at a cellular level in non-small cell lung carcinoma, the predominant type of lung cancer. Their goal was to uncover the reasons behind the varying responses of patients to immunotherapy treatments, as reported by a news agency.
Utilizing machine-learning techniques and computational methods, the research team analyzed how cancer cells interact and metabolize glucose, a vital nutrient for their growth, according to Associate Professor Arutha Kulasinghe from UQ's Frazer Institute.
"We delved into the intricate dynamics of cells, essentially examining their interactions within the complex structure of a tumor. Our findings indicated that specific metabolic neighborhoods correlate with both positive and negative responses to immunotherapy," Kulasinghe explained.
Immunotherapy, while effective for some, is expensive and only benefits a small fraction of patients. The researchers emphasized the necessity of identifying patients who may require alternative or combination therapies.
Lead author James Monkman noted that increased glucose uptake in cancer cells is linked to worse outcomes. "Cancer cells have a strong affinity for sugar, and we investigated the areas within the cells where glucose is processed differently," Monkman stated.
"It's possible for one region of a tumor to metabolize glucose in a manner distinct from another region," he added.
The research findings have been published in the journal Nature Communications. The next phase involves developing targeted therapies, such as metabolic inhibitors, to enhance the effectiveness of immunotherapy and ultimately facilitate precision medicine tailored to individual tumors. The researchers also plan to apply this approach to other cancer types.